• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.

作者信息

Nishida Marina, Takeichi Takuya, Kono Michihiro, Imanishi Akiko, Maekawa Naoki, Akiyama Masashi, Fukai Kazuyoshi

机构信息

Department of Dermatology, Osaka City General Hospital, Osaka, Japan.

Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

J Dermatol. 2020 Mar;47(3):e77-e78. doi: 10.1111/1346-8138.15228. Epub 2020 Jan 6.

DOI:10.1111/1346-8138.15228
PMID:31907962
Abstract
摘要

相似文献

1
Successful secukinumab treatment of recalcitrant juvenile generalized pustular psoriasis.司库奇尤单抗成功治疗顽固性青少年泛发性脓疱型银屑病。
J Dermatol. 2020 Mar;47(3):e77-e78. doi: 10.1111/1346-8138.15228. Epub 2020 Jan 6.
2
Palmoplantar pustulosis emerged on a case of generalized pustular psoriasis successfully treated by secukinumab.掌跖脓疱病出现在一例用司库奇尤单抗成功治疗的泛发性脓疱型银屑病患者身上。
J Dermatol. 2019 Dec;46(12):e468-e469. doi: 10.1111/1346-8138.15082. Epub 2019 Sep 9.
3
Successful treatment of generalized pustular psoriasis with secukinumab: a report of two cases.司库奇尤单抗成功治疗泛发性脓疱型银屑病：两例报告
Chin Med J (Engl). 2020 Nov 23;133(24):3015-3016. doi: 10.1097/CM9.0000000000001244.
4
Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting.在日常临床实践中，司库奇尤单抗对治疗顽固性掌跖银屑病和掌跖脓疱型银屑病有效。
J Am Acad Dermatol. 2022 Sep;87(3):705-709. doi: 10.1016/j.jaad.2022.05.047. Epub 2022 May 28.
5
Skin Infiltration of Pathogenic Migratory and Resident T Cells Is Decreased by Secukinumab Treatment in Psoriasis.在银屑病中，司库奇尤单抗治疗可减少致病性游走和驻留T细胞的皮肤浸润。
J Invest Dermatol. 2020 Oct;140(10):2073-2076.e6. doi: 10.1016/j.jid.2020.02.024. Epub 2020 Mar 19.
6
Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature.司库奇尤单抗与阿维A联合治疗泛发性脓疱型银屑病：一例病例报告及文献复习
J Int Med Res. 2024 Apr;52(4):3000605241247702. doi: 10.1177/03000605241247702.
7
Real-world data on the clinical use of secukinumab in pediatric generalized pustular psoriasis: A 48-week retrospective study.司库奇尤单抗治疗儿童泛发性脓疱型银屑病临床应用的真实世界数据：一项48周的回顾性研究。
J Am Acad Dermatol. 2023 Jan;88(1):243-246. doi: 10.1016/j.jaad.2022.04.064. Epub 2022 May 16.
8
Infantile generalized pustular psoriasis with excellent response to secukinumab: A case report.婴儿泛发性脓疱型银屑病对司库奇尤单抗反应良好：一例报告
Exp Dermatol. 2023 Aug;32(8):1296-1298. doi: 10.1111/exd.14784. Epub 2023 Mar 6.
9
Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis.司库奇尤单抗和阿维A在儿童泛发性脓疱型银屑病治疗中的真实世界数据。
J Dermatol. 2023 Feb;50(2):258-261. doi: 10.1111/1346-8138.16551. Epub 2022 Aug 18.
10
Successful treatment with secukinumab in a patient with generalized pustular psoriasis preceded by palmoplantar lesions.一名掌跖部病变先于泛发性脓疱型银屑病患者使用司库奇尤单抗治疗成功。
J Dermatol. 2023 Dec;50(12):e413-e414. doi: 10.1111/1346-8138.16919. Epub 2023 Aug 14.

引用本文的文献

1
Safety and effectiveness of secukinumab in Japanese patients with generalized pustular psoriasis: A post-marketing surveillance.司库奇尤单抗在日本泛发性脓疱型银屑病患者中的安全性和有效性：一项上市后监测。
J Dermatol. 2025 May;52(5):773-786. doi: 10.1111/1346-8138.17648. Epub 2025 Apr 3.
2
The update of treatment strategies in pediatrics with generalized pustular psoriasis in China.中国儿童泛发性脓疱型银屑病治疗策略的更新
Pediatr Investig. 2023 Aug 31;7(3):191-198. doi: 10.1002/ped4.12395. eCollection 2023 Sep.
3
Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
生物疗法在脓疱型银屑病治疗中的应用：新时代来临？
Clin Cosmet Investig Dermatol. 2023 Jun 28;16:1677-1690. doi: 10.2147/CCID.S407812. eCollection 2023.
4
Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability.司库奇尤单抗治疗儿童银屑病：患者选择与可接受性
Patient Prefer Adherence. 2023 Feb 16;17:421-431. doi: 10.2147/PPA.S350753. eCollection 2023.